Clinical Trial Update: Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating an anthracycline-free, taxane-based chemotherapy regimen in HER2-negative early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: West German Study Group | Conditions: Primary Breast Cancer, Her2 Non-overexpressing | Phase 3 | Status: COMPLETED